Please assess the completion status of the following clinical trial:

Trial Title: ED90 for Hyperbaric Bupivacaine in Super Obese Parturients

Study Design Characteristics:
- Allocation: NON_RANDOMIZED
- Intervention Model: SEQUENTIAL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: TRIPLE
- Phase: PHASE4
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* American Society of Anesthesiology (ASA) class 2 and 3~* English speaking~* Gestational age \> 36 weeks~* Scheduled for cesarean delivery under combined spinal epidural anesthesia~* 18 years or older~* BMI \> 50 kg/m2~Exclusion Criteria:~* History of past or current intravenous drug or chronic opioid abuse~* Allergy or contraindication to any study medications~* Intrapartum cesarean delivery under epidural anesthesia~* Cesarean delivery under general anesthesia

- Gender: FEMALE
- Minimum Age: 18 Years
- Maximum Age: 45 Years
- Healthy Volunteers: t

Study Arms:
- Starting dose of Bupivacaine (9 mg) (Type: EXPERIMENTAL): The starting dose of hyperbaric bupivacaine for the first patient in this study will be 9mg; the dose for the subsequent subject will be based on the response of the preceding subject as per the Narayana Rule, a modification of the biased-coin design (BCD) up-down sequential method (UDM).
- Subsequent dose (Type: EXPERIMENTAL): None

Based on this trial design, predict the completion outcome and termination type (if applicable).